BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16959246)

  • 1. Chronic idiopathic myelofibrosis (CIMF) resulting from a unique 3;9 translocation disrupting the janus kinase 2 (JAK2) gene.
    Mark HF; Sotomayor EA; Nelson M; Chaves F; Sanger WG; Kaleem Z; Caughron SK
    Exp Mol Pathol; 2006 Dec; 81(3):217-23. PubMed ID: 16959246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome 9p24 abnormalities: prevalence, description of novel JAK2 translocations, JAK2V617F mutation analysis and clinicopathologic correlates.
    Patnaik MM; Knudson RA; Gangat N; Hanson CA; Pardanani A; Tefferi A; Ketterling RP
    Eur J Haematol; 2010 Jun; 84(6):518-24. PubMed ID: 20331734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Numerical gain and structural rearrangements of JAK2, identified by FISH, characterize both JAK2617V>F-positive and -negative patients with Ph-negative MPD, myelodysplasia, and B-lymphoid neoplasms.
    Najfeld V; Cozza A; Berkofsy-Fessler W; Prchal J; Scalise A
    Exp Hematol; 2007 Nov; 35(11):1668-76. PubMed ID: 17976519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosis.
    Larsen TS; Hasselbalch HC; Pallisgaard N; Kerndrup GB
    Cancer Genet Cytogenet; 2007 Jan; 172(2):107-12. PubMed ID: 17213018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel SSBP2-JAK2 fusion gene resulting from a t(5;9)(q14.1;p24.1) in pre-B acute lymphocytic leukemia.
    Poitras JL; Dal Cin P; Aster JC; Deangelo DJ; Morton CC
    Genes Chromosomes Cancer; 2008 Oct; 47(10):884-9. PubMed ID: 18618714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications.
    Panani AD
    Cancer Lett; 2007 Sep; 255(1):12-25. PubMed ID: 17383090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of bone marrow involvement in malignant lymphoma using fluorescence in situ hybridization: possible utility in the detection of micrometastasis.
    Huh HJ; Min HC; Cho HI; Chae SL; Lee DS
    Cancer Genet Cytogenet; 2008 Oct; 186(1):1-5. PubMed ID: 18786435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivative (1)t(1;19)(p13;p13) in the setting of myelofibrosis with JAK2 V617F.
    Staropoli JF; Wadleigh M; Dal Cin P
    Cancer Genet Cytogenet; 2009 Jun; 191(2):109-10. PubMed ID: 19446748
    [No Abstract]   [Full Text] [Related]  

  • 10. Der(6)t(1;6)(q21-23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasia.
    Dingli D; Grand FH; Mahaffey V; Spurbeck J; Ross FM; Watmore AE; Reilly JT; Cross NC; Dewald GW; Tefferi A
    Br J Haematol; 2005 Jul; 130(2):229-32. PubMed ID: 16029451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemic recombinations involving heterochromatin in myeloproliferative disorders with t(1;9).
    Sambani C; La Starza R; Pierini V; Vandenberghe P; Gonzales-Aguilera JJ; Rigana H; Koumbi D; Manola KN; Stavropoulou C; Georgakakos VN; Pagoni M; Wlodarska I; Mecucci C
    Cancer Genet Cytogenet; 2005 Oct; 162(1):45-9. PubMed ID: 16157199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype.
    Larsen TS; Pallisgaard N; Møller MB; Hasselbalch HC
    Eur J Haematol; 2007 Dec; 79(6):508-15. PubMed ID: 17961178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular genetics in chronic myeloid leukemia with variant Ph translocation].
    Wu W; Li JY; Zhu Y; Qiu HR; Pan JL; Xu W; Chen LJ; Shen YF; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):470-3. PubMed ID: 17680547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.
    Zhan H; Spivak JL
    Clin Adv Hematol Oncol; 2009 May; 7(5):334-42. PubMed ID: 19521323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 9p24.3 breakpoint of a constitutional t(6;9)(p12;p24) in a patient with chronic lymphocytic leukemia maps close to the putative promoter region of the DMRT2 gene.
    Rüssel J; Dutta U; Wand D; Schlote D; Hansmann I
    Cytogenet Genome Res; 2009; 125(2):81-6. PubMed ID: 19729909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two alternatively spliced 5'BCR/3'JAK2 fusion transcripts in a myeloproliferative neoplasm with a three-way t(9;18;22)(p23;p11.3;q11.2) translocation.
    Impera L; Lonoce A; Fanfulla DA; Moreilhon C; Legros L; Raynaud S; Storlazzi CT
    Cancer Genet; 2011 Sep; 204(9):512-5. PubMed ID: 22018274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulomatous slack skin with a translocation t(3;9)(q12;p24).
    Ikonomou IM; Aamot HV; Heim S; Fosså A; Delabie J
    Am J Surg Pathol; 2007 May; 31(5):803-6. PubMed ID: 17460466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated genomic analysis using chromosomal microarray, fluorescence in situ hybridization and mate pair analyses: Characterization of a cryptic t(9;22)(p24.1;q11.2)/BCR-JAK2 in myeloid/lymphoid neoplasm with eosinophilia.
    Snider JS; Znoyko I; Lindsey KG; Morse J; Baughn LB; Hoppman NL; Pitel BA; Pearce KE; Schandl CA; Wolff DJ
    Cancer Genet; 2020 Aug; 246-247():44-47. PubMed ID: 32827877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression.
    Nanjangud G; Rao PH; Teruya-Feldstein J; Donnelly G; Qin J; Mehra S; Jhanwar SC; Zelenetz AD; Chaganti RS
    Cytogenet Genome Res; 2007; 118(2-4):337-44. PubMed ID: 18000388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case.
    Heiss S; Erdel M; Gunsilius E; Nachbaur D; Tzankov A
    Hum Pathol; 2005 Oct; 36(10):1148-51. PubMed ID: 16226118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.